0
enVVeno Medical Corporation Banner Image

enVVeno Medical Corporation

  • Ticker NVNO
    Exchange NASDAQ More
  • Industry Medical Appliances & Equipment More
  • Sector Healthcare More
enVVeno Medical Corporation Logo Image
  • 11-50 Employees
  • Based in Irvine, California
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease. The Company’s lead product, the VenoValve®, is a first-in-class implant being developed for the treatment of deep venous Chronic VenousMore Insufficiency (CVI). In healthy patients, valves inside the veins of the leg assist in propelling blood up the leg, and back to the heart and lungs. Affecting approximately 2.4 million people in the United States, CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Implanted into the femoral vein, the VenoValve is designed to act as a one-way valve, to help restore proper blood flow in the leg. The VenoValve is currently being evaluated in the SAVVE pivotal study.
REPORT RATINGS
4.8 / 5.0 (233)

enVVeno Medical Corporation reports have an aggregate usefulness score of 4.8 based on 233 reviews.

enVVeno Medical Corporation

Most Recent Annual Report

enVVeno Medical Corporation
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

enVVeno Medical Corporation Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!